Halozyme Therapeutics (HALO) Stock Price Target 2026

The average analyst price target for Halozyme Therapeutics is $92.76, 9.1% below the current price. Of 11 analysts, 7 rate it Buy and 4 Hold. Targets range from $47 to $149. The latest change came on Nov 6, 2026, when Leerink Partners downgraded Halozyme Therapeutics from Outperform to Market Perform and moved its price target from $110 to $117.